CB Insights names Delfina Care as a top 100 most promising private artificial intelligence company
.webp)
CB Insights, an AI analyst for market intelligence, named Delfina Care to its ninth annual AI 100, showcasing the top 100 most promising private artificial intelligence companies in the world.
The list recognizes early—and mid-stage startups that are leading the way in applying AI across industries and architectures. CB Insight’s research team picked winning companies based on CB Insights datasets, including deal activity, industry partnerships, team strength, investor strength, employee headcount, and proprietary Commercial Maturity and Mosaic scores. CB Insight’s also dug into Analyst Briefings submitted directly by startups.
Delfina is honored to be named as a top AI company in the world by CB Insights. Our machine learning care optimization technology is validated in collaboration with Mayo Clinic, helping to predict pregnancy complications, such as preeclampsia, as early as 12 weeks, enabling proactive intervention. Our award-winning hypertensive disorders model mitigates racial bias and supports equitable care. Insights are shared directly with care teams through the Delfina Provider Dashboard, improving early decision-making and efficiency by up to 50%. This approach enhances pregnancy outcomes while reducing complication costs.
“The AI 100 winners are future movers and shakers, taking big swings that will shape the future of AI,” said Manlio Carrelli, CEO at CB Insights. “This year’s cohort is pushing AI applications from emerging to emerged, working on everything from AI agents for complex processes to security and robotics. They’ve also zeroed in on new and promising technologies that might not be on the radar of many enterprises — multi-agent systems, novel computing and data curation approaches, and physical AI.”
Quick facts on the 2025 AI 100:
CB Insights names Delfina Care as a top 100 most promising private artificial intelligence company
CB Insights, an AI analyst for market intelligence, named Delfina Care to its ninth annual AI 100, showcasing the top 100 most promising private artificial intelligence companies in the world.
The list recognizes early—and mid-stage startups that are leading the way in applying AI across industries and architectures. CB Insight’s research team picked winning companies based on CB Insights datasets, including deal activity, industry partnerships, team strength, investor strength, employee headcount, and proprietary Commercial Maturity and Mosaic scores. CB Insight’s also dug into Analyst Briefings submitted directly by startups.
Delfina is honored to be named as a top AI company in the world by CB Insights. Our machine learning care optimization technology is validated in collaboration with Mayo Clinic, helping to predict pregnancy complications, such as preeclampsia, as early as 12 weeks, enabling proactive intervention. Our award-winning hypertensive disorders model mitigates racial bias and supports equitable care. Insights are shared directly with care teams through the Delfina Provider Dashboard, improving early decision-making and efficiency by up to 50%. This approach enhances pregnancy outcomes while reducing complication costs.
“The AI 100 winners are future movers and shakers, taking big swings that will shape the future of AI,” said Manlio Carrelli, CEO at CB Insights. “This year’s cohort is pushing AI applications from emerging to emerged, working on everything from AI agents for complex processes to security and robotics. They’ve also zeroed in on new and promising technologies that might not be on the radar of many enterprises — multi-agent systems, novel computing and data curation approaches, and physical AI.”
Quick facts on the 2025 AI 100:
CB Insights names Delfina Care as a top 100 most promising private artificial intelligence company
CB Insights, an AI analyst for market intelligence, named Delfina Care to its ninth annual AI 100, showcasing the top 100 most promising private artificial intelligence companies in the world.
The list recognizes early—and mid-stage startups that are leading the way in applying AI across industries and architectures. CB Insight’s research team picked winning companies based on CB Insights datasets, including deal activity, industry partnerships, team strength, investor strength, employee headcount, and proprietary Commercial Maturity and Mosaic scores. CB Insight’s also dug into Analyst Briefings submitted directly by startups.
Delfina is honored to be named as a top AI company in the world by CB Insights. Our machine learning care optimization technology is validated in collaboration with Mayo Clinic, helping to predict pregnancy complications, such as preeclampsia, as early as 12 weeks, enabling proactive intervention. Our award-winning hypertensive disorders model mitigates racial bias and supports equitable care. Insights are shared directly with care teams through the Delfina Provider Dashboard, improving early decision-making and efficiency by up to 50%. This approach enhances pregnancy outcomes while reducing complication costs.
“The AI 100 winners are future movers and shakers, taking big swings that will shape the future of AI,” said Manlio Carrelli, CEO at CB Insights. “This year’s cohort is pushing AI applications from emerging to emerged, working on everything from AI agents for complex processes to security and robotics. They’ve also zeroed in on new and promising technologies that might not be on the radar of many enterprises — multi-agent systems, novel computing and data curation approaches, and physical AI.”
Quick facts on the 2025 AI 100:
CB Insights names Delfina Care as a top 100 most promising private artificial intelligence company
CB Insights, an AI analyst for market intelligence, named Delfina Care to its ninth annual AI 100, showcasing the top 100 most promising private artificial intelligence companies in the world.
The list recognizes early—and mid-stage startups that are leading the way in applying AI across industries and architectures. CB Insight’s research team picked winning companies based on CB Insights datasets, including deal activity, industry partnerships, team strength, investor strength, employee headcount, and proprietary Commercial Maturity and Mosaic scores. CB Insight’s also dug into Analyst Briefings submitted directly by startups.
Delfina is honored to be named as a top AI company in the world by CB Insights. Our machine learning care optimization technology is validated in collaboration with Mayo Clinic, helping to predict pregnancy complications, such as preeclampsia, as early as 12 weeks, enabling proactive intervention. Our award-winning hypertensive disorders model mitigates racial bias and supports equitable care. Insights are shared directly with care teams through the Delfina Provider Dashboard, improving early decision-making and efficiency by up to 50%. This approach enhances pregnancy outcomes while reducing complication costs.
“The AI 100 winners are future movers and shakers, taking big swings that will shape the future of AI,” said Manlio Carrelli, CEO at CB Insights. “This year’s cohort is pushing AI applications from emerging to emerged, working on everything from AI agents for complex processes to security and robotics. They’ve also zeroed in on new and promising technologies that might not be on the radar of many enterprises — multi-agent systems, novel computing and data curation approaches, and physical AI.”
Quick facts on the 2025 AI 100:
CB Insights names Delfina Care as a top 100 most promising private artificial intelligence company
CB Insights, an AI analyst for market intelligence, named Delfina Care to its ninth annual AI 100, showcasing the top 100 most promising private artificial intelligence companies in the world.
The list recognizes early—and mid-stage startups that are leading the way in applying AI across industries and architectures. CB Insight’s research team picked winning companies based on CB Insights datasets, including deal activity, industry partnerships, team strength, investor strength, employee headcount, and proprietary Commercial Maturity and Mosaic scores. CB Insight’s also dug into Analyst Briefings submitted directly by startups.
Delfina is honored to be named as a top AI company in the world by CB Insights. Our machine learning care optimization technology is validated in collaboration with Mayo Clinic, helping to predict pregnancy complications, such as preeclampsia, as early as 12 weeks, enabling proactive intervention. Our award-winning hypertensive disorders model mitigates racial bias and supports equitable care. Insights are shared directly with care teams through the Delfina Provider Dashboard, improving early decision-making and efficiency by up to 50%. This approach enhances pregnancy outcomes while reducing complication costs.
“The AI 100 winners are future movers and shakers, taking big swings that will shape the future of AI,” said Manlio Carrelli, CEO at CB Insights. “This year’s cohort is pushing AI applications from emerging to emerged, working on everything from AI agents for complex processes to security and robotics. They’ve also zeroed in on new and promising technologies that might not be on the radar of many enterprises — multi-agent systems, novel computing and data curation approaches, and physical AI.”
Quick facts on the 2025 AI 100:
CB Insights names Delfina Care as a top 100 most promising private artificial intelligence company
CB Insights, an AI analyst for market intelligence, named Delfina Care to its ninth annual AI 100, showcasing the top 100 most promising private artificial intelligence companies in the world.
The list recognizes early—and mid-stage startups that are leading the way in applying AI across industries and architectures. CB Insight’s research team picked winning companies based on CB Insights datasets, including deal activity, industry partnerships, team strength, investor strength, employee headcount, and proprietary Commercial Maturity and Mosaic scores. CB Insight’s also dug into Analyst Briefings submitted directly by startups.
Delfina is honored to be named as a top AI company in the world by CB Insights. Our machine learning care optimization technology is validated in collaboration with Mayo Clinic, helping to predict pregnancy complications, such as preeclampsia, as early as 12 weeks, enabling proactive intervention. Our award-winning hypertensive disorders model mitigates racial bias and supports equitable care. Insights are shared directly with care teams through the Delfina Provider Dashboard, improving early decision-making and efficiency by up to 50%. This approach enhances pregnancy outcomes while reducing complication costs.
“The AI 100 winners are future movers and shakers, taking big swings that will shape the future of AI,” said Manlio Carrelli, CEO at CB Insights. “This year’s cohort is pushing AI applications from emerging to emerged, working on everything from AI agents for complex processes to security and robotics. They’ve also zeroed in on new and promising technologies that might not be on the radar of many enterprises — multi-agent systems, novel computing and data curation approaches, and physical AI.”
Quick facts on the 2025 AI 100:
CB Insights names Delfina Care as a top 100 most promising private artificial intelligence company
